2nd Circ. Backs Another Eli Lilly Win In Zyprexa MDL

Law360, Chicago (December 10, 2012, 4:41 PM EST) -- The Second Circuit preserved another Eli Lilly & Co. win Monday in a suit in multidistrict litigation alleging it failed to warn about diabetes risks tied to its antipsychotic Zyprexa, finding the two-year time limit on bringing such claims under Virginia law had run out.

In a summary order entered in one of the many appeals stemming from the MDL, a three-judge appeals panel ruled the district court had not erred by finding a former Zyprexa user's claim was barred by a statute of limitations and...
To view the full article, register now.